Package 71610-518-42

{"route": ["ORAL"], "spl_id": "1524482d-40bd-a0f9-e063-6394a90a1a37", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749"], "spl_set_id": ["abb32182-46ba-49d2-b2ac-13de2ecf802d"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1800 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-42)", "package_ndc": "71610-518-42", "marketing_start_date": "20240401"}, {"sample": false, "description": "3600 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-83)", "package_ndc": "71610-518-83", "marketing_start_date": "20210122"}], "brand_name": "Ranolazine", "product_id": "71610-518_1524482d-40bd-a0f9-e063-6394a90a1a37", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71610-518", "generic_name": "RANOLAZINE", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA212781", "marketing_category": "ANDA", "marketing_start_date": "20201027", "listing_expiration_date": "20261231"}